Zobrazeno 1 - 10
of 663
pro vyhledávání: '"Zhao Qian Liu"'
Publikováno v:
Pharmaceuticals, Vol 17, Iss 9, p 1118 (2024)
Lung cancer has the highest fatality rate among malignant tumors in the world. Finding new biomarkers of drug resistance is of great importance in the prognosis of lung cancer patients. We found that the polymorphisms of Adenylate Cyclase 1 (ADCY1) a
Externí odkaz:
https://doaj.org/article/9ee239a6e4044a959be0c15557d7a902
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/2a0f824e451040ab9b70185dafbc773a
Autor:
Zhi-Bin Wang, Jian Qu, Pan Xie, Zhi-Quan Yang, Chen-Xue Mao, Ying Zhang, Zheng-Wen He, Zhuan-Yi Yang, Xiao-Yuan Mao, Zhao-Qian Liu
Publikováno v:
BMC Genomics, Vol 23, Iss 1, Pp 1-12 (2022)
Abstract Background Seizures are a common symptom in glioma patients, and they can cause brain dysfunction. However, the mechanism by which glioma-related epilepsy (GRE) causes alterations in brain networks remains elusive. Objective To investigate t
Externí odkaz:
https://doaj.org/article/6131e6190bf140829c3c710378100246
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
PURPOSE: To explore the relationship between ATM, ATR and CAT polymorphisms and prognosis of lung cancer patients received platinum-based chemotherapy.METHODS: 404 patients with lung cancer who received platinum-chemotherapy were enrolled and DNA typ
Externí odkaz:
https://doaj.org/article/c21b1ace6a654477ba6df9a1b483f093
Autor:
Ting Zou, Jun-Yan Liu, Qun Qin, Jie Guo, Wen-Zhi Zhou, Xiang-Ping Li, Hong-Hao Zhou, Juan Chen, Zhao-Qian Liu
Publikováno v:
Biomedicines, Vol 11, Iss 12, p 3133 (2023)
Background: Lung cancer is still the most lethal malignancy in the world, according to the report of Cancer Statistics in 2021. Platinum-based chemotherapy combined with immunotherapy is the first-line treatment in lung cancer patients. However, the
Externí odkaz:
https://doaj.org/article/630db547cdcb4b88868f70de777885e6
Autor:
Zhi-Bin Wang, Shi-Long Jiang, Shao-Bo Liu, Jing-Bo Peng, Shuo Hu, Xu Wang, Wei Zhuo, Tong Liu, Ji-Wei Guo, Hong-Hao Zhou, Zhi-Quan Yang, Xiao-Yuan Mao, Zhao-Qian Liu
Publikováno v:
ACS Omega, Vol 6, Iss 29, Pp 18610-18622 (2021)
Externí odkaz:
https://doaj.org/article/3503a1ff382d4a69840f5a5fe65898d6
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Discoidin, CUB, and LCCL domain-containing protein 2 (DCBLD2) is a two-domain transmembrane protein-coding gene located on chromosome 3, the protein expressed by which acts as the membrane receptor of semaphorin and vascular endothelial growth factor
Externí odkaz:
https://doaj.org/article/737e531898084b529749ab2a775ef97b
Autor:
Jun-Yan Liu, Ting Zou, Ji-Ye Yin, Zhan Wang, Chong Liu, Han-Xue Huang, Fei-Xiang Ding, Meng-Rong Lei, Ying Wang, Min Liu, Zhao-Qian Liu, Li-Ming Tan, Juan Chen
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Objective: The purpose of this study was to investigate the associations of genetic variants in double-strand break (DSB) repair pathway genes with prognosis in patients with lung cancer treated with platinum-based chemotherapy.Methods: Three hundred
Externí odkaz:
https://doaj.org/article/7d7cad04d7c043e98b8651420f2c907f
Autor:
Ju-Yan Zheng, Jun-Yan Liu, Tao Zhu, Chong Liu, Ying Gao, Wen-Ting Dai, Wei Zhuo, Xiao-Yuan Mao, Bai-Mei He, Zhao-Qian Liu
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: Hepatocellular carcinoma (HCC) is a common and deadly malignancy worldwide. Current treatment methods for hepatocellular carcinoma have many disadvantages; thus, it is urgent to improve the efficacy of these therapies. Glycolysis is criti
Externí odkaz:
https://doaj.org/article/74c100d8aa6b42b0bb0d768b4f9d12c4
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundGlioblastoma multiforme (GBM), the most prevalent and aggressive of primary malignant central nervous system tumors (grade IV), has a poor clinical prognosis. This study aimed to assess and predict the survival of GBM patients by establishi
Externí odkaz:
https://doaj.org/article/526cc1af16c548d6a25d24ad02f3b66d